
Real brand kits. Real ads. Real output — pulled from live production batches, with the strategy notes that drove each call. No mockups. No staged renders. The work, on the record.
Norwegian joint-supplement positioning. Built for DACH 50–70 — the cohort that reads the label before they read the headline.




Four ads, four angles, one prospect. We led with the insight axis because Artroshield's buyer doesn't respond to pain theatre — they respond to learning something they didn't know about their own body. The Stat-Surround and Ingredient-Explosion variants give the same prospect two reasons to convert: the science and the formula. The Monochromatic wildcard runs after the safe variants have validated the audience — heritage as geography, no smiles, no lifestyle scaffolding. Reads like a state seal, not a supplement ad.
Male vitality, 40+, DACH. EFSA's zinc-to-testosterone claim is the only legally durable hook in this category — we built the whole batch around it.



Stat-Surround leads because the EFSA citation is the one claim that survives Meta's review pass and the customer's skepticism in the same breath. The ICP-Mirror variant is the same prospect at 6 AM — product-in-use, no hype, no models. The Variant version doubles down on the stat, sharper headline, same world. We ran these three over the wildcard that drifted from the brand palette — that one's holding for a rework. This is the batch you ship to a regulated category.